Page last updated: 2024-08-21

erythromycin and Lung Neoplasms

erythromycin has been researched along with Lung Neoplasms in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19904 (16.67)18.7374
1990's8 (33.33)18.2507
2000's11 (45.83)29.6817
2010's1 (4.17)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, M; Li, C; Li, T; Li, Y; Qi, Q; Wang, A; Wang, B; Xu, L; Zhang, Y1
Barletta, E; Cusano, F; Ferrara, G; Ingordo, V1
Sugiyama, Y1
Fujiwara, Y; Fukui, S; Ito, T; Izumiyama, N; Kashima, M; Miura, H; Sano, M; Sasaki, M1
Aikawa, A; Date, J; Hashizume, M; Kato, K; Kidokoro, T; Kimura, B; Takano, T; Takaoka, K; Tokimitsu, S; Yamagishi, M1
Mikasa, K1
Boonstra, A; Kummer, JA; Susanto, CR; Vonk-Noordegraaf, A1
Akamine, S; Kabahara, R; Mochinaga, H; Morino, S; Muraoka, M; Tsuchiya, S; Uchiyama, Y; Yamaoka, N1
Dall, L; Martin, ML1
Brun, Y; Brune, J; Fleurette, J; Forey, F; Gamondes, JP; Tebib, A1
Fujii, T; Kitamura, S; Suga, T; Sugiyama, Y1
Jamal, SA; Murphy, GF; Siu, LL; Skorecki, KL; Tobe, SW; Warner, E1
Hamada, K; Kita, E; Mikasa, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S1
Goto, G; Ieshiro, R; Iguchi, M; Okamura, J; Ota, T; Yuasa, K1
Furunishi, M; Kita, E; Maeda, K; Mashima, T; Mikasa, K; Narita, N; Sakamoto, M; Ueta, K1
Kitada, H; Konishi, Y; Murakawa, K; Sakitani, H; Sasaki, Y; Shiraiwa, K; Takahama, M; Tsujiuchi, T; Tsutsumi, M; Yoshimoto, M1
Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Murakawa, K; Narita, N; Sakamoto, M; Takahashi, K; Yoshimoto, E1
Hiyama, K; Ishioka, S; Jougasaki, Y; Maeda, A; Maeda, H; Nishisaka, T; Yamakido, M; Yokozaki, M1
Fujiwara, Y; Fukui, S; Ito, T; Izumiyama, N; Kashima, M; Miura, M; Sano, M; Sasaki, M; Watanabe, A1
De Souza, A; Jones, JA; Morgan, WE; Morris, DL1
Kudo, S1
Friedman, GD; Selby, JV1
Fireman, BH; Friedman, GD; Selby, JV1
Ambrogi, V; Cristino, B; Mineo, TC; Reggio, S1

Reviews

2 review(s) available for erythromycin and Lung Neoplasms

ArticleYear
[Contribution of Japanese researchers to progress in the field of pulmonary medicine in the last 100 years: New pharmacological action of macrolides].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2002, Jun-10, Volume: 91, Issue:6

    Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chronic Disease; Clarithromycin; Erythromycin; History, 20th Century; Humans; Japan; Lung Neoplasms; Respiratory Tract Infections

2002
[Clinical application of the new action of macrolide preparations to respiratory diseases].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999, Aug-10, Volume: 88, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Infections; Bronchiectasis; Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Humans; Immunologic Factors; Lung Neoplasms

1999

Trials

5 trial(s) available for erythromycin and Lung Neoplasms

ArticleYear
Intrapleural combination therapy with lobaplatin and erythromycin for non-small cell lung cancer-mediated malignant pleural effusion.
    Thoracic cancer, 2018, Volume: 9, Issue:8

    Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cyclobutanes; Erythromycin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Pleural Effusion, Malignant; Prospective Studies; Survival Analysis; Treatment Outcome

2018
Vinblastine and erythromycin: an unrecognized serious drug interaction.
    Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:3

    Topics: Aged; Carcinoma, Renal Cell; Constipation; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Muscle Spasticity; Neutropenia; Pain; Vinblastine

1995
[Lung cancer: progress in diagnosis and treatment. IV. Related topics: 2. Macrolides as biological response modifiers for the treatment of lung cancer].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1997, Jan-10, Volume: 86, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Erythromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Mice; Middle Aged

1997
[Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period].
    The Japanese journal of antibiotics, 2000, Volume: 53 Suppl A

    Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Erythromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Retrospective Studies

2000
High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:10

    Topics: Administration, Oral; Adult; Aged; Azithromycin; Biological Assay; Carcinoma, Bronchogenic; Chromatography, High Pressure Liquid; Drug Administration Schedule; Erythromycin; Humans; Lung; Lung Neoplasms; Middle Aged

1991

Other Studies

17 other study(ies) available for erythromycin and Lung Neoplasms

ArticleYear
Erlotinib-induced pustular eruption.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2009, Volume: 144, Issue:1

    Topics: Acneiform Eruptions; Administration, Cutaneous; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Erythromycin; Gels; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome

2009
[Effect of 14-membered ring macrolides on heparanase mRNA expression in lung cancer cells].
    The Japanese journal of antibiotics, 2001, Volume: 54 Suppl C

    Topics: Anti-Bacterial Agents; Cell Movement; Clarithromycin; Erythromycin; Fibroblast Growth Factor 2; Gene Expression; Glucuronidase; Hepatocyte Growth Factor; Humans; Lung Neoplasms; Platelet-Derived Growth Factor; RNA, Messenger; Tumor Cells, Cultured

2001
[Surgically resected lung cancer in patients complicated with diffuse interstitial pulmonary shadow].
    Kyobu geka. The Japanese journal of thoracic surgery, 2005, Volume: 58, Issue:1

    Topics: Aged; Erythromycin; Female; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Perioperative Care; Pneumonectomy; Postoperative Complications; Prednisolone; Prognosis; Pulse Therapy, Drug; Smoking; Survival Rate

2005
[New treatment not based on MIC for infectious diseases--making use of experience of macrolide long-term therapy].
    The Japanese journal of antibiotics, 2005, Volume: 58, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Animals; Bronchiectasis; Bronchitis, Chronic; Clarithromycin; Erythromycin; Female; Humans; Lung Neoplasms; Macrolides; Male; Mice; Middle Aged

2005
Nonresolving pneumonia in mycoplasma pneumoniae infection resembling a lung tumor.
    Respiration; international review of thoracic diseases, 2006, Volume: 73, Issue:2

    Topics: Anti-Bacterial Agents; Biopsy; Diagnosis, Differential; DNA, Bacterial; Erythromycin; Female; Humans; Lung; Lung Neoplasms; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction

2006
[The efficacy of perioperative administration of steroid and erythromycin in the surgery for lung cancer complicated with interstitial pneumonia].
    Kyobu geka. The Japanese journal of thoracic surgery, 2007, Volume: 60, Issue:10

    Topics: Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Erythromycin; Female; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Perioperative Care; Pneumonectomy; Postoperative Complications

2007
Emergence of multidrug-resistant Mycobacterium fortuitum during treatment.
    Chest, 1984, Volume: 85, Issue:3

    Topics: Carcinoma, Squamous Cell; Cefoxitin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Humans; Lung Neoplasms; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Tuberculosis, Pulmonary

1984
Levels of erythromycin in pulmonary tissue and bronchial mucus compared to those of amoxycillin.
    The Journal of antimicrobial chemotherapy, 1981, Volume: 8, Issue:6

    Topics: Administration, Oral; Aged; Amoxicillin; Bronchi; Erythromycin; Female; Humans; Injections, Intravenous; Lung; Lung Neoplasms; Male; Middle Aged; Mucous Membrane

1981
Bronchioloalveolar carcinoma with bronchorrhoea treated with erythromycin.
    The European respiratory journal, 1994, Volume: 7, Issue:12

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchi; Erythromycin; Humans; Lung Neoplasms; Male; Sputum

1994
[Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer].
    The Japanese journal of antibiotics, 1997, Volume: 50 Suppl A

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Erythromycin; Female; Humans; Immunologic Factors; In Vitro Techniques; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Male; Survival Rate

1997
Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats.
    Carcinogenesis, 2000, Volume: 21, Issue:2

    Topics: Adenocarcinoma; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Carcinogens; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cocarcinogenesis; Disease Progression; Drug Evaluation, Preclinical; Drug Synergism; Drugs, Chinese Herbal; Erythromycin; Gene Expression Regulation; Inflammation; Lung Neoplasms; Macrophages; Male; Neutrophils; Nitrosamines; Penicillins; Piroxicam; Plant Extracts; Pneumonia, Bacterial; Rats; Rats, Sprague-Dawley; Scutellaria baicalensis; Specific Pathogen-Free Organisms

2000
An autopsy case of diffuse panbronchiolitis associated with lung cancer.
    Internal medicine (Tokyo, Japan), 2000, Volume: 39, Issue:5

    Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Autopsy; Bronchiolitis; Erythromycin; Female; Humans; Lung Neoplasms; Prognosis

2000
Erythromycin and clarithromycin modulation of growth factor-induced expression of heparanase mRNA on human lung cancer cells in vitro.
    Mediators of inflammation, 2001, Volume: 10, Issue:5

    Topics: Anti-Bacterial Agents; Cell Movement; Clarithromycin; Erythromycin; Fibroblast Growth Factor 2; Gene Expression; Glucuronidase; Hepatocyte Growth Factor; Humans; Immunologic Factors; Lung Neoplasms; Platelet-Derived Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured

2001
[Respiratory tract diseases and infections].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, May-10, Volume: 80, Issue:5

    Topics: Bronchitis; Chronic Disease; Erythromycin; Humans; Immune Tolerance; Lung Neoplasms; Opportunistic Infections; Respiratory Tract Diseases; Respiratory Tract Infections

1991
Epidemiological screening for potentially carcinogenic drugs.
    Agents and actions. Supplements, 1990, Volume: 29

    Topics: Barbiturates; Breast Neoplasms; Carcinogens; Diazepam; Dose-Response Relationship, Drug; Erythromycin; Folic Acid; Humans; Information Systems; Lung Neoplasms; Multiple Myeloma; Neoplasms; Product Surveillance, Postmarketing; Vitamin E

1990
Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up.
    Cancer research, 1989, Oct-15, Volume: 49, Issue:20

    Topics: Anti-Bacterial Agents; Atropa belladonna; Carcinogens; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Esophageal Neoplasms; Folic Acid; Follow-Up Studies; Gastrointestinal Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neomycin; Neoplasms; Phenylbutazone; Piperidones; Plants, Medicinal; Plants, Toxic; Polymyxin B; Propantheline; Secobarbital; Sulfathiazoles; Vitamins

1989
[Short-term prophylaxis with erythromycin lactobionate in patients undergoing lung surgery].
    Minerva chirurgica, 1989, Nov-30, Volume: 44, Issue:22

    Topics: Adult; Aged; Drug Evaluation; Erythromycin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Premedication; Random Allocation; Respiratory Function Tests; Time Factors

1989